Patent details

Basic Information

Publication number:

EP3064579

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP161632146

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITIONS AND MEDICAL USES OF ENGINEERED HUMAN ARGINASES

French Title of Invention:

COMPOSITIONS PHARMACEUTIQUES ET UTILISATIONS MÉDICALES D'ARGINASES HUMAINES GÉNÉTIQUEMENT MODIFIÉES

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNGEN UND MEDIZINISCHE VERWENDUNGEN VON MANIPULIERTEN MENSCHLICHEN ARGINASEN

SPC Number:

Dates

Filing date:

02/11/2009

Grant date:

30/09/2020

EP Publication Date:

07/09/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

30/09/2020

EP B1 Publication Date:

30/09/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

02/11/2020

Expiration date:

02/11/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

23/09/2020

 

 

Name:

AERase, Inc.

Address:

901 S. MoPac Expressway Barton Plaza One, Suite 250, Austin, TX 78746, United States (US)

Inventor

1

Name:

Georgiou, George

Address:

United States (US)

2

Name:

Stone, Everett

Address:

United States (US)

Priority

Priority Number:

110218 P

Priority Date:

31/10/2008

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/48; A61P 35/00; C07K 19/00; C12N 9/50; C12N 15/57; C12N 15/62;

Publication

European Patent Bulletin

Issue number:

202040

Publication date:

30/09/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages